Overall, the effects of VEGF and its receptors, both tissue-level receptors and soluble receptors, are model and disease-dependent, and the soluble DR of VEGF have no real potential for application in clinical and epidemiologic studies looking at CV [48] or kidney [49] outcomes in CKD. Here, VEGFA is linked to chronic kidney disease.